Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma.

J Immunother Cancer · 2026 · PMC12853468 · PMID 41592893

Europe PMC DOI

hedged sentence

0.0770

closest p · 1.5× alpha

0.0770

boldest claim

The sentences

did not reach statistical significancep=0.077so close (0.05 < p ≤ 0.1)

In the ipi/nivo combination group, anti-RPLP2 was significantly associated with irAE risk (HR=1.63, p=0.010), while anti-KRT7 showed a similar trend that did not reach statistical significance (HR=1.27, p=0.077).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.